...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >ORAL ANTICOAGULANT PRESCRIPTION ANALYSIS FOR UTILISATION PATTERN AMONG IN-PATIENTS AT A TERTIARY CARE HOSPITAL
【24h】

ORAL ANTICOAGULANT PRESCRIPTION ANALYSIS FOR UTILISATION PATTERN AMONG IN-PATIENTS AT A TERTIARY CARE HOSPITAL

机译:三级医院住院患者口服抗菌素的处方分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: Selection of oral anticoagulants (OACs) in patients with thromboembolic diseases is complex and equivocal in nature, owing majorly to the non-adherence to standard clinical guidelines. Moreover, there is a scarcity of data on utilisation pattern of OACs in Indian population. Our primary objective was to analyse the prescribing pattern of OACs among in-patients with thromboembolic disorders. The secondary objective was to determine the significant predictors that affect their utilisation pattern. Methods: This prospective observational study examined the clinical data over 6 mo from in-patients on oral anticoagulation with warfarin and acenocoumarol. Patients were recruited into 2 study groups: coronary artery disease (CAD) and non-CAD to analyse the prescription pattern. Potential predictors of utilisation pattern were evaluated for significance with logistic regression analysis for CAD group. Results: Prescription analysis highlights preference of acenocoumarol (72.4%) over warfarin among 232 in-patients in the study. Lack of achievement of target international normalised ratio (INR) levels was noticed in 74.2% of the study population. 57.8% of cases belonged to CAD group (males 76.7%; mean age 59.4±13.5 y). Valvular heart disease (VHD) was the significant predictor (p =0.001) of warfarin utilisation among CAD patients while male gender, heart failure (HF) and arrhythmia were significant for acenocoumarol. Conclusion: Predominance of age<60 y and male gender was observed in the study. Acenocoumarol was preferred over warfarin in all the in-patient departments. VHD, male gender, HF and arrhythmia significantly affected the OAC utilisation.
机译:目的:血栓栓塞性疾病患者口服抗凝剂(OAC)的选择本质上是复杂且模棱两可的,这主要是由于不遵守标准临床指南。此外,印度人口中OAC的利用方式数据匮乏。我们的主要目的是分析血栓栓塞性疾病住院患者的OAC处方模式。次要目标是确定影响其使用模式的重要预测指标。方法:这项前瞻性观察性研究检查了住院患者6个月以上华法林和醋香豆酚口服抗凝的临床资料。将患者分为2个研究组:冠状动脉疾病(CAD)和非CAD,以分析处方模式。利用CAD组的logistic回归分析评估了利用模式的潜在预测指标的显着性。结果:处方分析显示,在该研究的232位住院患者中,乙酰香豆酚(72.4%)优于华法林。在74.2%的研究人群中未达到目标国际标准化比率(INR)水平。 57.8%的病例属于CAD组(男性为76.7%;平均年龄为59.4±13.5岁)。冠心病患者中瓣膜性心脏病(VHD)是使用华法林的重要预测指标(p = 0.001),而乙酰香豆酚的男性,心力衰竭(HF)和心律不齐则是男性。结论:在研究中观察到年龄<60岁和男性占优势。在所有住院科室中,苯甲香豆酚均优于华法林。 VHD,男性,HF和心律不齐严重影响了OAC的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号